Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritis.
Maxime SamsonHélène GreigertMarion CiudadClaire GerardThibault GhesquièreMalika TradMarc Corbera-BellaltaCoraline GenetSethi OuandjiClaudie CladièreMarine ThebaultKim Heang LyEric LiozonFrançois MaurierBoris BienvenuBenjamin TerrierLoïc GuillevinPierre CharlesValérie QuipourtHervé DevilliersPierre-Henry GabrielleCatherine Creuzot-GarcherGeorges TarrisLaurent MartinPhilippe SaasSylvain AudiaMaria Cinta CidBernard BonnottePublished in: Clinical & translational immunology (2021)
This study reports quantitative and functional disruptions in the regulatory immune response of GCA patients and demonstrates that, unlike glucocorticoids, tocilizumab improves Treg immune response.
Keyphrases
- immune response
- rheumatoid arthritis
- giant cell
- end stage renal disease
- dendritic cells
- ejection fraction
- toll like receptor
- juvenile idiopathic arthritis
- chronic kidney disease
- rheumatoid arthritis patients
- prognostic factors
- transcription factor
- emergency department
- inflammatory response
- disease activity
- adverse drug